G. Puglisi et al., INTERACTION OF NATURAL AND MODIFIED BETA-CYCLODEXTRINS WITH A BIOLOGICAL MEMBRANE MODEL OF DIPALMITOYLPHOSPHATIDYLCHOLINE, Journal of colloid and interface science, 180(2), 1996, pp. 542-547
Lipid vesicles made up of dipalmitoyl-sn-glycero-3-phosphocholine (DPP
C) were used as a biological membrane model to investigate the interac
tion between natural and modified beta-cyclodextrins and these membran
e bilayers. Differential scanning calorimetry was used to study the th
ermotropic behavior of the DPPC vesicles and any change caused by the
presence of cyclodextrins. The presence of dimethyl-beta-cyclodextrin
(DM-beta-CyD) triggered a reduction in the enthalpy values related to
the main transition peak from gel state to liquid crystal phase of DPP
C aqueous dispersions, as a function of the DM-beta-CyD molar fraction
: the larger the amount of DM-beta-CyD, the greater the reduction in D
elta H values. This effect was probably due to the ability of DM-beta-
CyD to extract and to complex the DPPC molecules forming the phospholi
pid vesicles. The presence of beta-cyclodextrin (beta-CyD) or hydroxyp
ropyl-beta-cyclodextrin (HP-beta-CyD) caused no particular alteration
in the thermotropic parameters of DPPC vesicles, whereas trimethyl-bet
a-cyclodextrin (TM-beta-CyD) at molar fractions higher than 0.12 cause
d broadening of the transition peak due to a possible interaction with
the hydrophobic part of the bilayers. Experiments on DPPC-cholesterol
(10 mol%) vesicles showed the capability of beta-CyD and TM-beta-CyD
to extract cholesterol from the ordered bilayer structures, triggering
an alteration in the lipid constituents of the membranes. HP-beta-CyD
caused no variation in the thermotropic parameters of the DPPC-choles
terol (10 mol%) vesicles. The findings show that HP-beta-CyD seems the
most suitable molecular drug carrier for in vivo administration. (C)
1996 Academic Press, Inc.